суббота, 3 марта 2012 г.

Wyeth posts 19 pct rise in 4th-qtr profit on broad drug sales advance

Wyeth on Thursday posted a 19 percent increase in fourth-quarter profit as the drugmaker's revenues rose 10 percent on strong sales across its product line.

The maker of children's vaccine Prevnar and the world's top-selling antidepressant, Effexor, reported net income of $1.02 billion (euro690 million), or 75 cents per share, in the quarter, up from $855.4 million, or 63 cents per share, a year earlier.

Madison-based Wyeth had total revenues of $5.76 billion (euro3.89 …

Комментариев нет:

Отправить комментарий